Neonatal drug withdrawal syndrome Completed Phase 3 Trials for Buprenorphine (DB00921)

Also known as: Drug withdrawal syndrome neonatal / Neonatal Abstinence Syndrome / Neonatal withdrawal symptoms from maternal use of drugs of addiction / Drug withdrawal syndrome in newborn / Withdrawal syndrome neonatal / Neonatal abstinence syndrome (disorder)

IndicationStatusPhase
DBCOND0101857 (Neonatal drug withdrawal syndrome)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01452789Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence SyndromeTreatment